< 回列表
歐大諒
- Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taiwan
- Yonglin institute of health, National Taiwan University, Taiwan
Ta-Cheng Tung’s Basic Cancer Research Award 董大成博士癌症基礎醫學研究傑出獎頒獎暨專題演講
| 角色 | 講師 |
| 日期時間 | 05/03 09:00 - 09:35 |
| 地點 | 701A |
學歷 / 訓練
2007, PhD., Department of Clinical Laboratory Sciences and Medical Biotechnology College of Medicine National Taiwan University
專業與研究經歷
2023 - Present, Professor, Graduate Institute of Oncology, College of Medicine, National Taiwan University
2018 - Present, Yonglin scholar, Yonglin institute of health, National Taiwan University
獲獎與榮譽
2022
TOS Young Investigator Award for Cancer Research, Taiwan Oncology Society
重要出版品
- 1. Lin L, Hsu C, Hsu CL, Jian CZ, Feng ZR, Chung CH, Cheng HY, Chang HY, Cheng AL, Yang MH, Ou DL*. Cabozantinib induces NLRP3-CASP1-GSDMD-dependent pyroptosis in hepatocellular carcinoma. Life Science. 2026 Mar 1;388:124210.
- 2. Lin YJ, Ou DL*, Su YY, Hsu CL, Hsiao CF, Ko BS, Chen SC, Wang HW, Wang JH, Wu YM, Jeng YM, Lee WC, Chou SC, Chen TW, Chiu CF, Lin JS, Hsieh CH, Lee CC, Shen YS, Cheng AL, Chen LT, Hsu C. Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: long-term efficacy and biomarker exploration. Journal of Hepatology 2026 Feb;84(2):316-328. (Co-first author)
- 3. Tseng TY, Hsieh CH, Huang HC, Wu YC, Hsu C, Hsu CL, Ou DL*, Juan HF. Transcriptional dynamics of CD8+ T-cell exhaustion in immune checkpoint inhibitor resistance at single-cell resolution. Molecular cancer. 2025 Dec 11;24(1):306. (Co- corresponding author)
- 4. Ou DL*, Liao ZX, Kempson IM, Li L, Yang PC, Tseng SJ. Nano-modified viruses prime the tumor microenvironment and promote the photodynamic virotherapy in liver cancer. Journal of Biomedical Science. 2024 Jan 2;31(1):1.
- 5. Jian CZ, Lin L, Hsu CL, Chen YH, Hsu C, Tan CT, Ou DL*. A potential novel cancer immunotherapy: Agonistic anti-CD40 antibodies. Drug Discovery Today. 2024 Mar;29(3):103893.